BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16548939)

  • 21. Bupropion for smoking cessation: a randomized trial.
    Simon JA; Duncan C; Carmody TP; Hudes ES
    Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE; Herskovic JE; Behm FM; Westman EC
    Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expressive writing as a smoking cessation treatment adjunct for young adult smokers.
    Ames SC; Patten CA; Werch CE; Schroeder DR; Stevens SR; Fredrickson PA; Echols JD; Pennebaker JW; Hurt RD
    Nicotine Tob Res; 2007 Feb; 9(2):185-94. PubMed ID: 17365749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking cessation advice for patients with chronic periodontitis.
    Nasry HA; Preshaw PM; Stacey F; Heasman L; Swan M; Heasman PA
    Br Dent J; 2006 Mar; 200(5):272-5; discussion 265. PubMed ID: 16528334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy.
    Strecher VJ; Shiffman S; West R
    Addiction; 2005 May; 100(5):682-8. PubMed ID: 15847626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior.
    Bohadana A; Nilsson F; Rasmussen T; Martinet Y
    Nicotine Tob Res; 2003 Feb; 5(1):111-6. PubMed ID: 12745512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR; Chen R; Lee JF; Ku CH; Lu RB
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of nicotine patch and nicotine lozenge in very heavy smokers.
    Shiffman S; Di Marino ME; Pillitteri JL
    J Subst Abuse Treat; 2005 Jan; 28(1):49-55. PubMed ID: 15723732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007].
    Broszkiewicz M; Sobala W; Drygas W
    Przegl Lek; 2008; 65(10):634-40. PubMed ID: 19189567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of motivation to quit smoking in methadone-maintained smokers enrolled in a smoking cessation trial.
    Shadel WG; Stein MD; Anderson BJ; Herman DS; Bishop S; Lassor JA; Weinstock M; Anthony JL; Niaura R
    Addict Behav; 2005 Feb; 30(2):295-300. PubMed ID: 15621400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of depression to smoking outcomes in a methadone-maintained population.
    Stein MD; Weinstock MC; Anderson BJ; Anthony JL
    J Addict Dis; 2007; 26(1):35-40. PubMed ID: 17439866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone-nicotine interactions in methadone maintenance treatment patients.
    Elkader AK; Brands B; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Jun; 29(3):231-8. PubMed ID: 19440076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
    Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.
    Cooperman NA; Lu SE; Richter KP; Bernstein SL; Williams JM
    Nicotine Tob Res; 2018 Aug; 20(9):1152-1156. PubMed ID: 29059389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
    Stein MD; Caviness CM; Kurth ME; Audet D; Olson J; Anderson BJ
    Drug Alcohol Depend; 2013 Dec; 133(2):486-93. PubMed ID: 23953658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention.
    Brendryen H; Kraft P
    Addiction; 2008 Mar; 103(3):478-84; discussion 485-6. PubMed ID: 18269367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.